Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · IEX Real-Time Price · USD
+0.01 (0.03%)
Jul 17, 2024, 4:00 PM EDT - Market closed

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had revenue of $597.40M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $143.64M. In the year 2023, Supernus Pharmaceuticals had annual revenue of $607.52M.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.59B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023607.52M-59.72M-8.95%
Dec 31, 2022667.24M87.46M15.09%
Dec 31, 2021579.78M59.38M11.41%
Dec 31, 2020520.40M127.64M32.50%
Dec 31, 2019392.76M-16.14M-3.95%
Dec 31, 2018408.90M106.66M35.29%
Dec 31, 2017302.24M87.24M40.57%
Dec 31, 2016215.00M67.54M45.80%
Dec 31, 2015147.47M54.79M59.12%
Dec 31, 201492.68M80.66M671.10%
Dec 31, 201312.02M10.54M712.09%
Dec 31, 20121.48M677.00K84.31%
Dec 31, 2011803.00K697.00K657.55%
Dec 31, 2010106.00K-37.82M-99.72%
Dec 31, 200937.93M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tilray Brands 743.25M
Alphatec Holdings 511.63M
InMode 466.26M
BioCryst Pharmaceuticals 355.40M
Kiniksa Pharmaceuticals 301.77M
MannKind 224.60M
Avadel Pharmaceuticals 55.14M
Spyre Therapeutics 688.00K
Revenue Rankings